These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


387 related items for PubMed ID: 32554843

  • 1. Effects of whole-body electromyostimulation exercise and caloric restriction on cardiometabolic risk profile and muscle strength in obese women with the metabolic syndrome: a pilot study.
    Reljic D, Konturek PC, Herrmann HJ, Neurath MF, Zopf Y.
    J Physiol Pharmacol; 2020 Feb; 71(1):. PubMed ID: 32554843
    [Abstract] [Full Text] [Related]

  • 2. Iron Beats Electricity: Resistance Training but Not Whole-Body Electromyostimulation Improves Cardiometabolic Health in Obese Metabolic Syndrome Patients during Caloric Restriction-A Randomized-Controlled Study.
    Reljic D, Herrmann HJ, Neurath MF, Zopf Y.
    Nutrients; 2021 May 13; 13(5):. PubMed ID: 34068089
    [Abstract] [Full Text] [Related]

  • 3. Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity study.
    Wittmann K, Sieber C, von Stengel S, Kohl M, Freiberger E, Jakob F, Lell M, Engelke K, Kemmler W.
    Clin Interv Aging; 2016 May 13; 11():1697-1706. PubMed ID: 27920508
    [Abstract] [Full Text] [Related]

  • 4. Effect of whole-body electromyostimulation and / or protein supplementation on obesity and cardiometabolic risk in older men with sarcopenic obesity: the randomized controlled FranSO trial.
    Kemmler W, Kohl M, Freiberger E, Sieber C, von Stengel S.
    BMC Geriatr; 2018 Mar 09; 18(1):70. PubMed ID: 29523089
    [Abstract] [Full Text] [Related]

  • 5. Whole-body electromyostimulation to fight sarcopenic obesity in community-dwelling older women at risk. Resultsof the randomized controlled FORMOsA-sarcopenic obesity study.
    Kemmler W, Teschler M, Weissenfels A, Bebenek M, von Stengel S, Kohl M, Freiberger E, Goisser S, Jakob F, Sieber C, Engelke K.
    Osteoporos Int; 2016 Nov 09; 27(11):3261-3270. PubMed ID: 27289534
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of Combined Whole-Body Electromyostimulation and Protein Supplementation on Local and Overall Muscle/Fat Distribution in Older Men with Sarcopenic Obesity: The Randomized Controlled Franconia Sarcopenic Obesity (FranSO) Study.
    Kemmler W, Grimm A, Bebenek M, Kohl M, von Stengel S.
    Calcif Tissue Int; 2018 Sep 09; 103(3):266-277. PubMed ID: 29675640
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial.
    Schink K, Herrmann HJ, Schwappacher R, Meyer J, Orlemann T, Waldmann E, Wullich B, Kahlmeyer A, Fietkau R, Lubgan D, Beckmann MW, Hack C, Kemmler W, Siebler J, Neurath MF, Zopf Y.
    BMC Cancer; 2018 Sep 12; 18(1):886. PubMed ID: 30208857
    [Abstract] [Full Text] [Related]

  • 10. Effects of Whole-Body Electromyostimulation on the Energy-Restriction-Induced Reduction of Muscle Mass During Intended Weight Loss.
    Willert S, Weissenfels A, Kohl M, von Stengel S, Fröhlich M, Kleinöder H, Schöne D, Teschler M, Kemmler W.
    Front Physiol; 2019 Sep 12; 10():1012. PubMed ID: 31456693
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Whole-body electromyostimulation and protein supplementation favorably affect sarcopenic obesity in community-dwelling older men at risk: the randomized controlled FranSO study.
    Kemmler W, Weissenfels A, Teschler M, Willert S, Bebenek M, Shojaa M, Kohl M, Freiberger E, Sieber C, von Stengel S.
    Clin Interv Aging; 2017 Sep 12; 12():1503-1513. PubMed ID: 28989278
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of protein source during weight loss on body composition, cardiometabolic risk and physical performance in abdominally obese, older adults: a pilot feeding study.
    Beavers KM, Gordon MM, Easter L, Beavers DP, Hairston KG, Nicklas BJ, Vitolins MZ.
    J Nutr Health Aging; 2015 Jan 12; 19(1):87-95. PubMed ID: 25560821
    [Abstract] [Full Text] [Related]

  • 15. Effects of exercise and caloric restriction on insulin resistance and cardiometabolic risk factors in older obese adults--a randomized clinical trial.
    Yassine HN, Marchetti CM, Krishnan RK, Vrobel TR, Gonzalez F, Kirwan JP.
    J Gerontol A Biol Sci Med Sci; 2009 Jan 12; 64(1):90-5. PubMed ID: 19164269
    [Abstract] [Full Text] [Related]

  • 16. Whole-Body Electromyostimulation Combined With Individualized Nutritional Support Improves Body Composition in Patients With Hematological Malignancies - A Pilot Study.
    Schink K, Reljic D, Herrmann HJ, Meyer J, Mackensen A, Neurath MF, Zopf Y.
    Front Physiol; 2018 Jan 12; 9():1808. PubMed ID: 30618820
    [Abstract] [Full Text] [Related]

  • 17. Once-Weekly Whole-Body Electromyostimulation Increases Strength, Stability and Body Composition in Amateur Golfers. A Randomized Controlled Study.
    Zink-Rückel C, Kohl M, Willert S, von Stengel S, Kemmler W.
    Int J Environ Res Public Health; 2021 May 25; 18(11):. PubMed ID: 34070315
    [Abstract] [Full Text] [Related]

  • 18. Whole-body electromyostimulation as a means to impact muscle mass and abdominal body fat in lean, sedentary, older female adults: subanalysis of the TEST-III trial.
    Kemmler W, von Stengel S.
    Clin Interv Aging; 2013 May 25; 8():1353-64. PubMed ID: 24130433
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Very low-volume interval training improves nonalcoholic fatty liver disease fibrosis score and cardiometabolic health in adults with obesity and metabolic syndrome.
    Reljic D, Konturek PC, Herrmann HJ, Siebler J, Neurath MF, Zopf Y.
    J Physiol Pharmacol; 2021 Dec 25; 72(6):. PubMed ID: 35485357
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.